跳至主要内容
临床试验/NCT03638583
NCT03638583招募中不适用

Alzheimer Prevention Trials (APT) Webstudy

University of Southern California1 个研究点 分布在 1 个国家目标入组 200,000 人开始时间: 2017年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200,000
试验地点
1
主要终点
Enrollment into Alzheimer's prevention research studies

研究概览

简要总结

The goal of the Alzheimer Prevention Trials (APT) Webstudy is to accelerate enrollment for Alzheimer's disease (AD) clinical trials by identifying and tracking individuals who may be at higher risk for developing AD dementia.

详细描述

The APT Webstudy will use web-based cognitive testing and questionnaires to generate a risk score which will be used to identify individuals who may be at an increased risk for developing AD dementia.

Individuals who join the APT Webstudy will register at https://www.aptwebstudy.org/, sign an electronic informed consent form (ICF), provide basic demographic information and participate in web-based cognitive testing. Participants will return the APT Webstudy quarterly (every 3 months) to complete the cognitive testing again.

Based on the risk score and changes identified in the cognitive testing results, participants will be invited to visit a partnering clinical trial site for an in-person visit with biomarker testing and clinical assessment.

The combined results of the web-based assessments, with the biomarker and clinical assessments, will allow an adaptive statistical algorithm to improve the selection of those at highest risk for developing AD.

To Join the APT Webstudy, please visit https://www.aptwebstudy.org/.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • male or female at least 50 years of age
  • no evidence of dementia
  • willing to participate in remote longitudinal cognitive testing and possible referral for biomarker assessment based on risk

排除标准

  • N/A. Anyone can register for the APT Webstudy, however, only individuals identified using the risk algorithm will be referred for in-person biomarker assessments.

结局指标

主要结局

Enrollment into Alzheimer's prevention research studies

时间窗: 5 years

次要结局

  • Referral into prevention research studies(5 years)
  • Number of individuals enrolled into Alzheimer's prevention studies(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paul S. Aisen

Professor

University of Southern California

研究点 (1)

Loading locations...

相似试验